KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Encompass Health (EHC) Cost of Revenue: 2009-2025

Historic Cost of Revenue for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $231.1 million.

  • Encompass Health's Cost of Revenue rose 1417.98% to $231.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $868.8 million, marking a year-over-year increase of 1124.2%. This contributed to the annual value of $802.6 million for FY2024, which is 1161.17% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Cost of Revenue is $231.1 million, which was up 1417.98% from $213.8 million recorded in Q2 2025.
  • Encompass Health's 5-year Cost of Revenue high stood at $231.1 million for Q3 2025, and its period low was $151.4 million during Q3 2021.
  • Its 5-year average for Cost of Revenue is $183.9 million, with a median of $177.9 million in 2023.
  • Data for Encompass Health's Cost of Revenue shows a peak YoY increase of 10826.56% (in 2021) and a maximum YoY decrease of 734.39% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Encompass Health's Cost of Revenue stood at $153.7 million in 2021, then rose by 10.67% to $170.1 million in 2022, then rose by 8.64% to $184.8 million in 2023, then rose by 11.69% to $206.4 million in 2024, then grew by 11.97% to $231.1 million in 2025.
  • Its last three reported values are $231.1 million in Q3 2025, $213.8 million for Q2 2025, and $217.5 million during Q1 2025.